PUCARA RESOURCES CORPORATION
Pucara Resources is a privately held company that focuses on precious metals exploration and project generator. It controls twelve early-stage, precious and base metals properties in central and southern Peru. It was founded in 2005 and is headquartered in Vancouver, Canada.
PUCARA RESOURCES CORPORATION
Social Links:
Industry:
Construction Mining Precious Metals
Founded:
2005-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.pucara.ca
Total Employee:
1+
Status:
Active
Contact:
+1 303 900 2150
Total Funding:
6.82 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS COVID-19 UNPKG Amazon Oregon Region Leaflet JS Leaflet
Similar Organizations
Aguila Copper
Aguila Copper is an exploration and development company that focuses on copper for the energy transition.
Commercial Metals Company
Commercial Metals is a vertically integrated, Fortune 500 steel company that recycles, manufactures, fabricates, and trades steel globally.
Congruex
Congruex is a multi-national organization that specializes in turn-key broadband network construction and engineering.
Paringa Resources
Paringa Resources is an emerging US based energy provider developing the high margin.
Russel Metals
Russel Metals Inc. is one of the largest North American suppliers of metal products, with operations across Canada and the United States.
Current Employees Featured
Founder
Stock Details
More informations about "Pucara Resources Corporation"
About Us | Zucara Therapeutics
In 2024, Zucara raised US$20M in a Series B financing with existing investor, the Perceptive Xontogeny Venture Fund and strategic investor, Sanofi to complete Zucara’s ongoing Phase …See details»
Prevent hypoglycemia in people with diabetes | Zucara …
Meeting a critical need to help prevent hypoglycemia in people with diabetes. Zucara Therapeutics Inc. is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in people with diabetes.Preventing …See details»
Zucara Therapeutics Secures Additional Funding from GlycoNet …
May 2, 2022 The project was granted nearly $150,000, which Zucara will more than double match to fund its preclinical efficacy study of ZT-01 for T2D. Mitacs has awarded Zucara and …See details»
JDRF Funds Zucara Therapeutics’ Approach to Preventing …
Sep 21, 2017 NEW YORK, USA and TORONTO, Canada, September 21, 2017 — As Global Biotech Week begins in more than 20 countries, JDRF, the leading organization funding type 1 …See details»
GlycoNet-supported Zucara Therapeutics Inc. named Emerging …
Feb 6, 2025 Congratulations to the Zucara Therapeutics team on receiving the 2025 Emerging Company of the Year award from Life Sciences Ontario. ... The company has raised over …See details»
TIAP FEATURES: Zucara Therapeutics – Building on Canada’s Rich …
Zucara attracted over US$9M in subsequent funding from organizations such as JDRF International, The Helmsley Charitable Trust, NRC-IRAP, MITACS, and GlycoNet. This …See details»
Zucara Therapeutics Inc. - Life Sciences British Columbia
Zucara Therapeutics is developing ZT-01, a first-in-class, once-daily therapeutic to prevent insulin-induced hypoglycemia in patients using insulin therapy. ZT-01 is designed to inhibit …See details»
Team Building in the Life Sciences: Fireside Chat with Zucara, …
Mar 21, 2025 Michael has been CEO of Zucara Therapeutics since 2016 and has advanced the company from preclinical discovery into Phase 2 clinical trials securing over US$50 million in …See details»
Breakthrough T1D Funds Zucara Therapeutics’ Approach to …
Sep 21, 2017 NEW YORK, USA and TORONTO, Canada, September 21, 2017 — As Global Biotech Week begins in more than 20 countries, Breakthrough T1D, the leading organization …See details»
Zucara Therapeutics Inc. - Company Profile - leadsontrees.com
Zucara Therapeutics Inc. Zucara Therapeutics, a CDRD and MaRS Innovation portfolio company, is developing the first drug therapy to prevent hypoglycemia in people with diabetes. Our first …See details»
Zucara - University of Toronto Entrepreneurship
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes. ... The University of Toronto has been recognized as best-in-class by one of the leading …See details»
New Drug to Prevent Hypoglycemia Enters Clinical Trials
Jun 15, 2023 On February 8, 2022 Zucara Therapeutics Inc., a diabetes life sciences company announced that the peer-reviewed journal, Diabetes, Obesity and Metabolism, published a …See details»
Zucara Therapeutics Announces Strategic Investment from Sanofi …
Nov 12, 2024 TORONTO, ON – Zucara Therapeutics Inc., (“Zucara” or the “Company”) a diabetes life sciences company developing ZT-01, the first once-daily therapeutic to prevent …See details»
adMare Portfolio Company, Zucara Therapeutics Secures …
Toronto, Canada, May 2, 2022 – Zucara Therapeutics Inc., a diabetes life sciences company developing the first once-daily therapeutic to prevent insulin-induced hypoglycemia (low blood …See details»
Zucara Therapeutics Announces Additional Funding
Toronto, Canada, June 15, 2023 – Zucara Therapeutics Inc., (“Zucara” or the “Company”), a diabetes-focused life sciences company developing the first once-daily therapeutic to prevent …See details»
Susan Peers Joins Zucara’s Leadership Team
Mar 13, 2019 Zucara Therapeutics Inc., a life sciences company developing the first once-daily therapeutic to prevent hypoglycemia in people with Type 1 diabetes and other types of insulin …See details»
Zucara Therapeutics Secures US$3.9M from the Helmsley …
“It is a unique opportunity for us to work with the Helmsley Charitable Trust, an organization that is deeply involved in bringing Type 1 diabetes (T1D) technologies and therapies to people with …See details»
Zucara Therapeutics Positive Proof of Concept Data Secures …
Sep 19, 2022 TORONTO, CANADA – Zucara Therapeutics Inc., (“Zucara” or the “Company”) a diabetes life sciences company developing the first once-daily therapeutic to prevent …See details»
Zucara Therapeutics - Life Sciences Ontario Site - LSO Member …
Zucara Therapeutics is developing ZT-01, a first-in-class, once-daily therapeutic to prevent insulin-induced hypoglycemia in patients using insulin therapy. ZT-01 is designed to inhibit …See details»
New funding expands drug research for diabetes hypoglycemia prevention
Oct 29, 2020 New funding will expand the development of a diabetes drug designed to prevent insulin-induced low blood glucose levels (hypoglycemia) to include use in Type 2 diabetes …See details»